227 related articles for article (PubMed ID: 28765910)
21. Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
Yamada S; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Ishikawa D; Shimada M
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S436-42. PubMed ID: 24566861
[TBL] [Abstract][Full Text] [Related]
22. High STAT4 expression is a better prognostic indicator in patients with hepatocellular carcinoma after hepatectomy.
Wubetu GY; Utsunomiya T; Ishikawa D; Yamada S; Ikemoto T; Morine Y; Iwahashi S; Saito Y; Arakawa Y; Imura S; Kanamoto M; Zhu C; Bando Y; Shimada M
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S721-8. PubMed ID: 24965572
[TBL] [Abstract][Full Text] [Related]
23. Increased Expression of Circulating Cancer Stem Cell Markers During the Perioperative Period Predicts Early Recurrence After Curative Resection of Hepatocellular Carcinoma.
Choi GH; Kim GI; Yoo JE; Na DC; Han DH; Roh YH; Park YN; Choi JS
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1444-52. PubMed ID: 25791790
[TBL] [Abstract][Full Text] [Related]
24. Loss of function of Notch1 identifies a poor prognosis group of early stage hepatocellular carcinoma following hepatectomy.
Liu J; Liu JF; Wang K; Yan ZL; Wan XY; Huang AM; Wang YZ; Li J; Xia Y; Shi LH; Jiao BH; Zhang Y; Shen F
Oncol Rep; 2015 Dec; 34(6):3174-86. PubMed ID: 26398566
[TBL] [Abstract][Full Text] [Related]
25. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M
Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021
[TBL] [Abstract][Full Text] [Related]
26. NADPH Oxidase 1 and NADPH Oxidase 4 Have Opposite Prognostic Effects for Patients with Hepatocellular Carcinoma after Hepatectomy.
Ha SY; Paik YH; Yang JW; Lee MJ; Bae H; Park CK
Gut Liver; 2016 Sep; 10(5):826-35. PubMed ID: 27282266
[TBL] [Abstract][Full Text] [Related]
27. High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.
Wubetu GY; Morine Y; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Ikemoto T; Saito YU; Imura S; Shimada M
Anticancer Res; 2016 Feb; 36(2):757-62. PubMed ID: 26851035
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
[TBL] [Abstract][Full Text] [Related]
29. High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma.
Wang YY; Qi LN; Zhong JH; Qin HG; Ye JZ; Lu SD; Ma L; Xiang BD; Li LQ; You XM
Sci Rep; 2017 Feb; 7():42199. PubMed ID: 28181486
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
31. SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma.
Zhang T; Cao C; Wu D; Liu L
Tumour Biol; 2016 Feb; 37(2):2379-85. PubMed ID: 26373735
[TBL] [Abstract][Full Text] [Related]
32. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.
Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236
[TBL] [Abstract][Full Text] [Related]
33. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
[TBL] [Abstract][Full Text] [Related]
34. Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma.
Jeng KS; Sheen IS; Tsai YC
Arch Surg; 2004 Oct; 139(10):1055-60. PubMed ID: 15492142
[TBL] [Abstract][Full Text] [Related]
35. Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.
Morimoto O; Nagano H; Miyamoto A; Fujiwara Y; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Dono K; Umeshita K; Nakamori S; Sakon M; Monden M
Surg Today; 2005; 35(12):1033-41. PubMed ID: 16341483
[TBL] [Abstract][Full Text] [Related]
36. High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma.
Zhang Y; Liu P; Jiang Y; Dou X; Yan J; Ma C; Fan Q; Wang W; Su F; Tang H; Su X
Pathol Oncol Res; 2016 Apr; 22(2):367-75. PubMed ID: 26563279
[TBL] [Abstract][Full Text] [Related]
37. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
[TBL] [Abstract][Full Text] [Related]
38. Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio.
Zhou L; Rui JA; Zhou WX; Wang SB; Chen SG; Qu Q
Pathol Res Pract; 2017 Jul; 213(7):824-830. PubMed ID: 28554743
[TBL] [Abstract][Full Text] [Related]
39. Carboxypeptidase E is a prediction marker for tumor recurrence in early-stage hepatocellular carcinoma.
Huang SF; Wu HD; Chen YT; Murthy SR; Chiu YT; Chang Y; Chang IC; Yang X; Loh YP
Tumour Biol; 2016 Jul; 37(7):9745-53. PubMed ID: 26803519
[TBL] [Abstract][Full Text] [Related]
40. Expression of prothymosin alpha predicts early recurrence and poor prognosis of hepatocellular carcinoma.
Ha SY; Song DH; Hwang SH; Cho SY; Park CK
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):171-7. PubMed ID: 25865690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]